Vnitr Lek 2007, 53(11):1144-1146

Vplyv obezity na genovú expresiu adiponektínu a jeho receptoru v subkutánnom tukovom tkanive - editorial

D. Gašperíková
Laboratórium diabetu a DIABGENE, Ústav experimentálnej endokrinológie Slovenskej akadémie vied, Bratislava, Slovenská republika, vedúci laboratória prof. MUDr. Iwar Klimeš, DrSc.

Received: August 21, 2007; Published: November 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Gašperíková D. Vplyv obezity na genovú expresiu adiponektínu a jeho receptoru v subkutánnom tukovom tkanive - editorial. Vnitr Lek. 2007;53(11):1144-1146.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Zhang Y, Proenca R, Maffei M et al. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425-432. Go to original source... Go to PubMed...
    2. Calabro P, Yeh ET. Obesity, inflammation, and vascular disease: the role of the adipose tissue as an endocrine organ. Subcell Biochem 2007; 42: 63-91. Go to original source... Go to PubMed...
    3. Waki H, Yamauchi T, Kamon J et al. Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. J Biol Chem 2003; 278: 4053-4063. Go to original source... Go to PubMed...
    4. Pajvani UB, Du X, Combs TP et al. Structure-function studies of the adipocyte-secreted hormones Acrp30/adiponectin. Implications for metabolic regulation and bioactivity. J Biol Chem 2003; 278: 9073-9085. Go to original source... Go to PubMed...
    5. Wang B, Jenkins JR, Trazhurn P. Expression and secretion of inflammation-related adipokines by human adipocyte differentiated in culture: integrated response to TNF-α. Am J Physiol Endocrinol Metab 2005; 288: E731-E740. Go to original source... Go to PubMed...
    6. Yu YH, Zhu H. Chronological changes in metabolism and functions of cultured adipocytes: a hypothesis for cell aging in mature adipocytes. Am J Physiol Endocrinol Metab 2004; 286: E402-E410. Go to original source... Go to PubMed...
    7. Weyer C, Funahashi T, Tanaka S et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001; 86: 1930-1935. Go to original source... Go to PubMed...
    8. Hotta K, Funahasi T, Bodkin NL et al. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkey. Diabetes 2001; 50: 1126-1133. Go to original source... Go to PubMed...
    9. Steffes MW, Gross MD, Schreiner PJ et al. Serum adiponectin in young adults - interactions with central adiposity, circulating levels of glucose, and insulin resistance: the CARDIA study. Ann Epidemiol 2004; 14: 492-498. Go to original source... Go to PubMed...
    10. Kadowaki T, Yamauchi T. Adiponectin and Adiponectin receptors. Endocr Rev 2005; 26: 439-451. Go to original source... Go to PubMed...
    11. Retnakaran R, Hanley AJ, Raif N et al. Reduced adiponectin concentrations in women with gestational diabetes: a potential factor in progression to type 2 diabetes. Diabetes Care 2004; 29: 799-800. Go to original source... Go to PubMed...
    12. Pischon T, Girman CJ, Hotamisligil GS et al. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 2004; 291: 1730-1737. Go to original source... Go to PubMed...
    13. Shetty GK, Economides PA, Horton ES et al. Circulation adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity id diabeteic patients and subjects at risk for diabetes. Diabetes Care 2004; 27: 2450-2457. Go to original source... Go to PubMed...
    14. Yamauchi T, Kamon J, Ito Y et al. Cloning of adiponectin receptros that mediate antidiabetic metabolic effects. Nature 2003; 423: 762-769. Go to original source... Go to PubMed...
    15. Tsuchida A, Yamauchi T, Ito Y et al. Insulin/Foxo 1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity. J Biol Chem 2004; 279: 30817-30822. Go to original source... Go to PubMed...
    16. Civitarese AE et al. Adiponectin receptors gene expression and insulin sensitivity in non-diabetic Mexican Americans with or without family history of type 2 diabetes. Diabetologia 2004; 47: 816-820. Go to original source... Go to PubMed...
    17. Berg AH, Du Combs TPX, Brownlee M et al. The adipocyte-secreted proteins Acrp30 enhances hepatic insulin action. Nat Med 2001; 7: 947-953. Go to original source... Go to PubMed...
    18. Yamauchi T, Kamon J, Waki H et al. The fat-derivated hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001; 7: 941-946. Go to original source... Go to PubMed...
    19. Yamauchi T, Kamon J, Waki H et al. Globular adiponecitn protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis. J Biol Chem 2003; 278: 2461-2468. Go to original source... Go to PubMed...
    20. Whitehead JP, Richards AA, Hickman IJ et al. Adiponectin - a key adipokine in the metabolic syndrome. Diabetes Obes Metab 2006; 8: 264-280. Go to original source... Go to PubMed...
    21. Garaulet M, Viguerie N, Porubsky S et al. Adiponectin gene expression and plasma values in obese women during very-low-calorie diet. Relationship with cardiovascular risk factors and insulin resistance. J Clin Endocrinol Metab 2004; 89: 756-760. Go to original source... Go to PubMed...
    22. Lacinová, Michalský D, Kasalický M et al. Vliv obezity na genovou expresi adiponektinu a jeho receptorů v subkutánní tukové tkáni. Vnitř Lék 2007; 53(11): 1190-1197. Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.